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NS4B H1NS4B protein from hepatitis C virus (HCV) is a highly hydrophobic protein inducing a rearrangement of
endoplasmic reticulum membranes responsible of the HCV replication process. Different helical elements
have been found in the N- and C- terminal domains of the protein, which seem to be responsible for many key
aspects of the viral replication process. In this work we have carried out a study of the binding and interaction
withmodel biomembranes of peptide NS4BH1, patterned after segment H1, one of these C-terminal previously
identiﬁed segments. We show that NS4BH1 partitions into phospholipid membranes; its membrane activity is
modulated by lipid composition, interacting preferentially with negatively charged phospholipids as well as
with sphingomyelin. Furthermore, the change in its sequence prevents the resulting peptide from interacting
with the membrane. These data would support its role in the interaction of NS4B with the membrane and
suggest that the region where this peptide resides could be involved in the membrane alteration which must
occur in the HCV replication and/or assembly process.S, 5-Doxyl-stearic acid; BPI,
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The emergence and resurgence of many animal and human viral
pathogens have many causes, but one of the most important is the
lack of effective antiviral therapies [1]. This is the case of hepatitis C
virus (HCV), an enveloped positive single-stranded RNA virus, which
belongs to the genus Hepacivirus within the family Flaviviridae, the
major cause of liver disease. With more than 180 million people
infected worldwide [2], its high persistence, no protective vaccine and
limited therapeutic agents, this disease has emerged as a serious
healthcare problem on a global scale [3,4].HCV entry into the host cell is achieved by the fusion of viral and
cellular membranes, replicates its genome in a membrane-associated
replication complex, and morphogenesis has been suggested to take
place in the endoplasmic reticulum (ER) ormodiﬁed ERmembranes [5].
The variability of the HCV proteins gives the virus the ability to escape
the host immune surveillance system and notably hampers the
development of an efﬁcient vaccine. HCV has a single-stranded genome
which encodes a polyprotein, cleaved by a combination of cellular and
viral proteases to produce the mature structural and non-structural
(NS) proteins [3,6]. Details aboutHCV replication process remain largely
unclear, but most if not all of the HCV non-structural proteins (NS)
proteins are involved and function in a complex web of protein-protein
interactions [6,7]. The fact that all NS proteins are localized together
with newly synthesized viral RNA on the ER or membranes originating
from it [8–10] supports this hypothesis.
Non-structural protein 4B (NS4B) protein, a fundamental player in
the HCV replicative process and the least characterized HCV protein, is
a highly hydrophobic protein associated with membranes of an
ER-derived modiﬁed compartment [11]. It has recently been shown
that NS4B is palmitoylated in the C-terminal region of the protein; its
N-terminal cytoplasmic region has potent polymerization activity [12]
and is engaged in virus assembly and release [13]. Interestingly, the
expressionofNS4B induces the formationof the so calledmembranous
web [14], which has been postulated to be the HCV RNA replication
complex. Thus, a function of NS4B might be to induce a speciﬁc
membrane alteration that serves as a scaffold for the formation of the
HCV replication complex and therefore has a critical role in the HCV
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determination of this protein is very difﬁcult. NS4B is likely to be
anchored to themembrane and be an integral membrane proteinwith
four or more transmembrane domains [11,15,16].
The C-terminal part of NS4B reveals signiﬁcant similarities through-
out all investigated viruses of the Flaviviridae family. Two α-helical
elements have been predicted, the ﬁrst α-helix (H1) approximately
from amino acid 1912 to 1924 and the second α-helix (H2)
approximately from amino acid 1940 to 1963, pointing out to a yet
unknown common function of the C-terminal globular part in
Flaviviridae [17]. These α-helical elements have been reported to be
potential targets of HCV replication inhibitors [18]. Previous studies
from our group studying the effect of NS4B-derived peptide libraries on
model membrane integrity have helped us to understand the
mechanisms underlying the interaction between NS4B andmembranes
[19]. These results allowed us to propose the location of different
segments in these proteins that are implicated in protein-lipid and
protein-protein interactions. One of those segments was located where
the H1 region resides. In the present study, we report the binding and
interaction of a peptide corresponding to the ﬁrst of the two predicted
amphipathic helices (peptide NS4BH1) both in aqueous solution and in
the presence of different membrane model systems and deﬁne it as a
membrane interacting domain. We show that NS4BH1 strongly parti-
tions into phospholipidmembranes, interacts with them, and is located
at themembrane interface,modulates the phospholipid phase behavior
and changes its secondary structure upon binding to the membrane.
These results would suggest that this NS4B element is an essential
constituent of the interaction between the protein and the membrane
andmight shed light into the speciﬁc function of theNS4Bprotein in the
viral cycle.
2. Materials and methods
2.1. Reagents
Strictly speaking, HCV NS4B spans from residue 1712 to residue 1972
of theHCVpolyproteinprecursor.However, and to avoid any confusion, in
thisworkwe are going to use theHCVNS4B numbering scheme, i.e., from
residue 1 to residue 261. Peptides NS4BH1 (sequence 198GEGAVQWMNR-
LIAFASRG
215
) and scrambled peptide NS4BH1SC (SAVRNAFIGQGMGR-
WEAL) were synthesized with N-terminal acetylation and C-terminal
amidationon an automaticmultiple synthesizer (GenemedSynthesis, San
Antonio, TX, USA). The peptide was puriﬁed by reverse-phase high-
performance liquid chromatography (Vydac C-8 column, 250×4.6 mm,
ﬂow rate 1 ml/min, solvent A, 0.1% triﬂuoroacetic acid, solvent B, 99.9
acetonitrile and 0.1% triﬂuoroacetic acid) to N95% purity, and its
composition and molecular mass were conﬁrmed by amino acid analysis
and mass spectrometry. Since triﬂuoroacetate has a strong infrared
absorbance at approximately 1673 cm­1, which interferes with the
characterization of the peptide Amide I band [20], residual triﬂuoroacetic
acid, used both in peptide synthesis and in the high-performance liquid
chromatography mobile phase, was removed by four lyophilisation/
solubilisation cycles in 10 mMHCl [21]. Peptide was solubilized in water/
TFE at 50% (v/v). Bovine brain phosphatidylserine (BPS), bovine liver L-α-
phosphatidylinositol (BPI), cholesterol (CHOL), egg phosphatidic acid
(EPA), egg L-α-phosphatidylcholine (EPC), egg sphingomyelin (ESM),
egg trans-steriﬁed L-α-phosphatidylethanolamine (TPE), tetramyristoyl
cardiolipin (CL), 1,2-dimyristoylphosphatidylserine (DMPS), 1,2-dimy-
ristoylphosphatidic acid (DMPA), 1,2-dimyristoylphosphatidylcholine
(DMPC), 1,2-dimyristoylphosphatidylglycerol (DMPG) and N-palmitoyl-
D-erythro-sphingosylphosphorylcholine (PSM) were obtained from
Avanti Polar Lipids (Alabaster, AL, USA). The lipid composition of the
synthetic ER was EPC/CL/BPI/TPE/BPS/EPA/ESM/Chol at a molar ratio of
59:0.37:7.4:18:3.1:1.2:3.4:7.8 [22]. 5-Carboxyﬂuorescein (CF, N95% by
HPLC), 5-doxyl-stearic acid (5-NS), 16-doxyl-stearic acid (16-NS),
deuterium oxide (99.9%), Triton X-100, EDTA and HEPESwere purchasedfrom Sigma-Aldrich (Madrid, Spain). 1,6-Diphenyl-1,3,5-hexatriene
(DPH), and 1-(4-trimethylammoniumphenyl)-6-phenyl-1,3,5-hexa-
triene (TMA-DPH) were obtained from Molecular Probes (Eugene, OR).
All other chemicals were commercial samples of the highest purity
available (Sigma-Aldrich, Madrid, Spain). Water was deionized, twice-
distilled and passed through a Milli-Q equipment (Millipore Ibérica,
Madrid, Spain) to a resistivity higher than 18 MΩ cm.
2.2. Vesicle preparation
Aliquots containing the appropriate amount of lipid in chloroform-
methanol (2:1 vol/vol) were placed in a test tube, the solvents were
removed by evaporation under a stream of O2-free nitrogen, and
ﬁnally, traces of solvents were eliminated under vacuum in the dark
for N3 h. The lipidﬁlmswere resuspended in an appropriate buffer and
incubated either at 25 °C or 10 °C above the phase transition
temperature (Tm) with intermittent vortexing for 30 min to hydrate
the samples and obtain multilamellar vesicles (MLV). The samples
were frozen and thawed ﬁve times to ensure complete homogeniza-
tion and maximization of peptide/lipid contacts with occasional
vortexing. Large unilamellar vesicles (LUV) with a mean diameter of
0.1 μm were prepared from MLV by the extrusion method [23] using
polycarbonate ﬁlters with a pore size of 0.1 μm (Nuclepore Corp.,
Cambridge, CA, USA). For infrared spectroscopy, aliquots containing
the appropriate amount of lipid in chloroform/methanol (2:1, v/v)
were placed in a test tube containing 200 μg of dried lyophilized
peptide. After vortexing, the solvents were removed by evaporation
under a stream of O2-free nitrogen, and ﬁnally, traces of solvents were
eliminated under vacuum in the dark for more than 3 h. The samples
were hydrated in 100 μl of D2O buffer containing 20 mM HEPES,
100 mM NaCl, 0.1 mM EDTA, pH 7.4 and incubated at 10 °C above the
Tm of the phospholipidmixturewith intermittent vortexing for 45 min
to hydrate the samples and obtain MLV. The samples were frozen and
thawed as above. Finally the suspensions were centrifuged at
15,000 rpm at 25 °C for 10 min to remove the possibly peptide
unbound to the membranes. The pellet was resuspended in 25 μl of
D2O buffer and incubated for 45 min at 10 °C above the Tm of the lipid
mixture, unless stated otherwise. The phospholipid and peptide
concentrations were measured by methods described previously
[24,25].
2.3. Membrane leakage and peptide binding to vesicles
LUVs with a mean diameter of 0.1 μm were prepared as indicated
above in buffer containing 10 mMTris, 20 mMNaCl, pH 7.4, and CF at a
concentration of 40 mM. Non-encapsulated CFwas separated from the
vesicle suspension through a Sephadex G-50 ﬁltration column
(Pharmacia, Uppsala, Sweden) eluted with buffer containing 10 mM
Tris, 100 mMNaCl, 1 mMEDTA, pH 7.4.Membrane rupture (leakage of
intraliposomal CF) was assayed by treating the probe-loaded lipo-
somes (ﬁnal lipid concentration, 0.125 mM) with the appropriate
amounts of peptide on microtiter plates using a microplate reader
(FLUORstar; BMG Labtech, Offenburg, Germany), stabilized at 25 °C
with the appropriate amounts of peptide, each well containing a ﬁnal
volume of 170 μl. The medium in the microtiter plates was continu-
ously stirred to allow the rapid mixing of peptide and vesicles. One
hundred percent release was achieved by adding Triton X-100 to
either the microtiter plate to ﬁnal concentration of 0.5% (w/w).
Changes in ﬂuorescence intensity were recorded with excitation and
emission wavelengths set at 492 and 517 nm, respectively. Leakage
was quantiﬁed on a percentage basis as previously described [26,27].
Steady-state ﬂuorescence spectra were recorded in a SLM Aminco
8000 C spectroﬂuorometer with excitation and emission wavelengths
of 290 and 348 nm, respectively, and 4 nm spectral bandwidths.
Measurements were carried out in 10 mM Tris, 100 mM NaCl, EDTA
0.1 mM, pH 7.4. Intensity values were corrected for dilution, and the
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Partition coefﬁcients KP (i.e. the amount of peptide bound to the
bilayer as a fraction of the total peptide present in the system) were
obtained as described previously [28–30].
2.4. Acrylamide quenching of Trp emission, quenchingwith lipophylic depth
probes and steady-state ﬂuorescence anisotropy
Aliquots from a 4 M solution of the water-soluble quencher were
added to the solution-containingpeptide in the presence and absence of
liposomes at a peptide/lipid molar ratio of 1:100. The results obtained
were corrected for dilution and the scatter contribution was derived
from acrylamide titration of a vesicle blank. Aliquots of TMA-DPH or
DPH inN,N′-dimethylformamidewere directly added intoMLVs formed
in 10 mM Tris, 100 mM NaCl, EDTA 0.1 mM, pH 7.4 to obtain a probe/
lipid molar ratio of 1:500. Samples were incubated for 15 or 60 min
when TMA-DPH or DPH were used, respectively, 10 °C above the gel to
liquid-crystalline phase transition temperature Tm of the phospholipid
mixture. Afterwards, the peptides were added to obtain a peptide/lipid
molar ratio of 1:15 and incubated 10 °C above the Tmof each lipid for 1 h,
with occasional vortexing. All ﬂuorescence studies were carried using
5 mm×5 mm quartz cuvettes in a ﬁnal volume of 400 μl (315 μM lipid
concentration). The steady-stateﬂuorescence anisotropywasmeasured
with an automated polarization accessory using a Varian Cary Eclipse
ﬂuorescence spectrometer, coupled to a Peltier for automatic temper-
ature change. Samples were excited at 360 nm (slit width, 5 nm) and
ﬂuorescence emission was recorded at 430 nm (slit width, 5 nm).
Quenching studieswith lipophylic probeswereperformedbysuccessive
addition of small amounts of 5-NS or 16-NS in ethanol to peptide
samples incubated with LUV. The ﬁnal concentration of ethanol was
kept below 2.5% (v/v) to avoid any signiﬁcant bilayer alterations. After
each addition an incubation period of 15 min was kept before the
measurement. The datawere analyzed as previously described [27]. The
Stern–Volmer quenching constant, KSV, obtained from the Stern–
Volmer equation, represents the quencher concentration at which 50%
of the intensity is quenched and it is therefore a measure of the
accessibility of Trp to the quencher molecule [31].
2.5. Differential scanning calorimetry
MLVswere formed as stated above in 20 mMHEPES, 100 mMNaCl,
0.1 mM EDTA, pH 7.4. The peptide was added to obtain a peptide/lipid
molar ratio of 1:15. The ﬁnal volume was 1.2 ml (0.5 mM lipid
concentration), and incubated 10 °C above the Tm of each phospho-
lipid for 1 h with occasional vortexing. DSC experiments were
performed in a VP-DSC differential scanning calorimeter (MicroCal
LLC, MA) under a constant external pressure of 30 psi in order to avoid
bubble formation, and samples were heated at a constant scan rate of
60 °C/h. Experimental data were corrected from small mismatches
between the two cells by subtracting a buffer baseline prior to data
analysis. The excess heat capacity functions were the analyzed by
using Origin 7.0 (Microcal Software). The thermograms were deﬁned
by the onset and completion temperatures of the transition peaks
obtained from heating scans. In order to avoid artifacts due to the
thermal history of the sample, the ﬁrst scan was never considered;
second and further scans were carried out until a reproducible and
reversible pattern was obtained.
2.6. Infrared spectroscopy
Approximately 25 μl of a pelleted sample in D2O was placed
between two CaF2 windows separated by 56-μm-thick Teﬂon spacers
in a liquid demountable cell (Harrick, Ossining, NY). The spectra were
obtained in a Bruker IFS55 spectrometer using a deuterated triglycine
sulfate detector. Each spectrum was obtained by collecting 250
interferogramswith a nominal resolution of 2 cm­1, transformed usingtriangular apodization and, in order to average background spectra
between sample spectra over the same time period, a sample shuttle
accessory was used to obtain sample and background spectra. The
spectrometer was continuously purgedwith dry air at a dew point of ­
40 °C in order to remove atmospheric water vapour from the bands of
interest. All samples were equilibrated at the lowest temperature for
20 min before acquisition. An external bath circulator, connected to
the infrared spectrometer, controlled the sample temperature. For
temperature studies, samples were scanned using 2 °C intervals and a
2-min delay between each consecutive scan. The data were analyzed
as previously described [26,30].
3. Results
Through the analysis of hydrophobicity, hydrophobic moments
and interfacial hydrophobicity distribution along the NS4B sequence
as well as the effect of a HCV NS4B derived peptide library on
membrane rupture, we have previously identiﬁed two zones of highly
hydrophobic character [19]. These zones approximately correspond to
the proposed α-helical elements predicted in the C-terminal part of
NS4B, i.e., H1, of approximately 13 residues in length, and H2,
comprising approximately 23 residues [17]. Since they could mediate
the interaction with similar domains of other HCV NS proteins, with
other host proteins or with the membrane it is very interesting to
investigate the binding and interaction with membrane model
systems of these highly hydrophobic regions of NS4B [3]. As shown
in Table 1, the region where H1 resides is signiﬁcantly conserved
among the major genotypes of HCV. The conservation of this pattern
across different strains of HCV indicates that this sequence is likely to
be an important region in NS4B protein. Taking into account these
results, as well as the above mentioned literature data concerning the
membrane-mediated HCV replication process modulated by NS4B, we
have performed an in-depth study of H1 peptide (from residue 198 to
residue 215, HCV NS4B numbering), i.e., peptide NS4BH1 (Table 1). In
order to discern any differences between the NS4BH1 sequence and its
amino acid composition, we have studied also a scrambled peptide,
NS4BH1SC (Table 1). We have investigated their binding and
interaction with different membrane model systems, as well as
characterized the structural changes taking place in both the peptides
and the phospholipid molecules.
3.1. Membrane leakage
In order to explore the possible interaction of the NS4BH1 peptide
with phospholipid model membranes, we studied the effect of the
NS4BH1 and NS4BH1SC peptides on the release of encapsulated
ﬂuorophores trapped inside model membranes composed of diverse
lipids [32,33]. The extent of leakage observed at different lipid-to-
peptide ratios and the effect of lipid composition is shown in Fig. 1A.
The NS4BH1 peptide was able to induce the release of the internal
contents of the liposomes in a dose-dependent manner. The NS4BH1
peptide induced a high percentage of leakage (90%), even at lipid/
peptide ratios of 30:1, for liposomes composed of EPC/EPA at a molar
ratio of 5:2. Lower but signiﬁcant leakage values were observed for
liposomes containing EPC (65%), EPA/CHOL at a molar ratio of 5:1
(60%), BPS/CHOL at a molar ratio of 5:1 (50%), EPC/BPS/CHOL at a
molar ratio of 5:3:1 (50%), and BPS/CHOL at a molar ratio of 5:1 (45%).
Lower values were obtained for liposomes composed of synthetic ER
membranes (35%), EPC/TPE/CHOL at a molar ratio of 5:3:1 (35%), EPC/
CHOL at a molar ratio of 5:1 (20%) and EPC/ESM/CHOL at a molar ratio
of 5:1:1 (20%). These results indicate that the peptide affects more
signiﬁcantlymembranes containing negatively charged phospholipids
rather than those containing zwitterionic ones. Remarkably, the
scrambled peptide NS4BH1SC did not produce any signiﬁcant leakage
for any of the liposome compositions as shown in Fig. 1A. These data
Table 1
Alignment (clustalw2) for reference strains representing the major genotypes of
hepatitis C virus. Alignment of residues 198–215 (HCV NS4B numbering) is shown. The
consensus sequence is shown beneath the alignment. Symbol * stand for identical
residues. The sequence of the peptides studied in this work is emphasized in bold.
GENOTYPE_STRAIN SEQUENCE
2c_BEBE1 GEGAVQWMNRLIAFASRG
2k_VAT96 GEGAVQWMNRLIAFASRG
2b_JPUT971017 GEGAVQWMNRLIAFASRG
2i_D54 GEGAVQWMNRLIAFASRG
2a_HC-J6 GEGAVQWMNRLIAFASRG
1a_1 GEGAVQWMNRLIAFASRG
1a_H77 GEGAVQWMNRLIAFASRG
1c_HC-G9 GEGAVQWMNRLIAFASRG
1b_Con1 GEGAVQWMNRLIAFASRG
1b_HC-J4 GEGAVQWMNRLIAFASRG
1g_1804 GEGAVQWMNRLIAFASRG
4a_ED43 GEGAVQWMNRLIAFASRG
4d_24 GEGAVQWMNRLIAFASRG
4k_PB65185 GEGAVQWMNRLIAFASRG
4f_CM_DAV9905 GEGAVQWMNRLIAFASRG
3a_NZL1 GEGAVQWMNRLIAFASRG
3b_Tr-Kj GEGAVQWMNRLIAFASRG
3k_JK049 GEGAVQWMNRLIAFASRG
5a_EUH1480 GEGAVQWMNRLIAFASRG
6c_Th846 TEGAAQWMNRLIAFASRG
6d_VN235 SEGATQWMNRLIAFASRG
6t_D49 TEGAAQWMNRLIAFASRG
6e_D42 SEGAAQWMNRLIAFASRG
6f_C-0044 SEGANQWMNRLIAFASRG
6a_D85 SEGATQWMNRLIAFASRG
6h_VN004 SEGATQWMNRLIAFASRG
6k_VN405 AEGATQWMNRLIAFASRG
6g_JK046 SEGAAQWMNRLIAFASRG
6a_6a33 AEGANQWMNRLIAFASRG
6b_Th580 SEGANQWMNRLIAFASRG
7a_QC69 SEGVTQWMNRLIAFASRG
consensus **. *************
NS4BH1 GEGAVQWMNRLIAFASRG
NS4BH1SC SAVRNAFIGQGMGRWEAL
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crucial to observe any membranotropic effect.
Interestingly, it has been shown that the active replication
complexes of HCV might be localized in lipid rafts, composed
predominantly of ESM and CHOL [34,35]. Fig. 1B shows the extent of
leakage for liposomes composed of different molar ratios of EPC, ESM
and CHOL. Signiﬁcant leakage values were observed for EPC/ESM/
CHOL membranes at molar ratios of 5:2:0, 5:5:1, 5:4:1 and 5:3:1
(70–90%). Lower but signiﬁcant values were observed for EPC/ESM/
CHOLmembranes atmolar ratios of 5:2:1 and 5:2:2 (40–60%). For EPC/
ESM/CHOL membranes at molar ratios of 5:1:1, 5:2:3 and 5:2:4
leakage values were observed between 5 and 20%. As a general trend,
the higher the ESM content and the lower the CHOL, the higher the
leakage is (Fig. 1C). For different lipid/peptide ratios this trend is
clearly visible, since increasing the relative content of ESM and at the
same time decreasing the relative content of CHOL, the leakage values
increases steadily (Fig. 1C).
Since the NS4B protein is associated with membranes of the ER or
an ER-derived modiﬁed compartment [11], we have studied the effect
of the NS4BH1 peptide on membrane rupture using a complex lipid
composition resembling the ERmembrane as well as the effect of each
component of the complex mixture (Fig. 1D). Since the synthetic ER
complex membrane used in the previous experiments was composed
of EPC, CL, BPI, TPE, BPS, EPA, ESM and CHOL at a molar ratio of
59:0.37:7.4:18:3.1:1.2:3.4:7.8 [22], we have designed an ER synthetic
membrane composed of EPC/CL/BPI/TPE/BPS/EPA/ESM/CHOL at a
molar ratio of 58:6:6:6.6:6:6:6 (ER58:6). This complex mixture is
very useful in order to study the effect of each lipid component on the
interaction of the peptidewith themembrane. As shown in Fig. 1D, theNS4BH1 peptide was able of rupturing the synthetic ER membranes
signiﬁcantly, since, at lipid/peptide ratios of 25:1 and 30:1, 95–85% of
leakage was attained. Removing either TPE or CL from the mixture
hardly any effect was observed on leakage, since the leakage values
observed were about 85%. When CHOL, EPA and BPI were removed
from the mixture, leakage values between 40 and 70% were found. A
more signiﬁcant effect was observed when ESM and BPS were
eliminated from the mixture, since leakage values of about 20–30%
were observed for lipid/peptide ratios of 25:1 and 30:1 (Fig. 1D). These
results conﬁrm the speciﬁc effect of the NS4BH1 peptide on negatively
charged phospholipids as well as sphingomyelin containing mem-
branes, since their removal decreased signiﬁcantly the observed effect
in the synthetic ER complex membrane.
3.2. Binding of NS4BH1 peptide to lipid vesicles
The ability of the NS4BH1 peptide to interact with membranes was
determined from ﬂuorescence studies of the peptide intrinsic Trp [36]
using liposomes containing different phospholipid compositions at
different lipid/peptide ratios (Fig. 2A). In order to observe any speciﬁc
interaction of the peptide with any speciﬁc type of lipid, the model
membranes were composed of zwitterionic and negatively charged
phospholipids aswell as ESMandCHOL atdifferentmolar ratios. The Trp
ﬂuorescence intensity of the NS4BH1 peptide greatly increased upon
increasing the lipid/peptide ratio using membranes composed of either
EPA/CHOL or BPS/CHOL at molar ratios of 5:1, indicating a signiﬁcant
change on the environment of the Trp moiety of the peptide in the
presence of these negatively charged lipids (Fig. 2A). A signiﬁcant
change on the Trp ﬂuorescence intensity of the NS4BH1 peptide was
observed also for membranes composed of EPC/EPA at a molar ratio of
5:2; smaller but signiﬁcant changes were observed for EPC/BPS at a
molar ratio of 5:2 and EPC/ESM/CHOL at a molar ratio of 5:3:1 (Fig. 2A).
The change on the Trp ﬂuorescence of the peptide has permitted us to
obtain its partition coefﬁcient, KP, for different membrane compositions
(Table 2). KP values in the range 105 were obtained, indicating that the
peptide was bound to the membrane surface with high afﬁnity
[28,36–38]. If we suppose that the ﬂuorescence intensity of the Trp
residue is related to the peptide location in the membrane [31], the
peptide insert more deeply in membranes composed of negatively
charged phospholipids than on membranes composed of zwitterionic
ones. The NS4BH1 peptide has a positive net formal charge of +1 at
neutral pH, so that an electrostatic effectmight be the reason to observe
a signiﬁcant increase of Trp ﬂuorescence in the presence of anionic
membranes than in the presence ofmembranes containing zwitterionic
phospholipids. However, electrostatic attraction is not the only element
that is playing a role, since theNS4BH1SCpeptide, having the sameamino
acid composition, i.e., the same positive net formal charge of +1 at
neutral pH, is affected much less signiﬁcantly in the presence of
membranes containing negatively charged phospholipids than the
NS4BH1 peptide (not shown). Comparing the data shown in Figs. 1A and
2A, a relatively good relationship exists between the Trp ﬂuorescence
intensity of thepeptides andmembrane rupture, i.e., the deeper location
of the peptides, the higher the CF leakage is.
3.3. Location and penetration of NS4BH1 peptide in the bilayer
To assess the accessibility of the Trp residue of the NS4BH1 peptide
to the aqueous environment before and after binding to membranes
having different phospholipid compositions, the water-soluble
quencher acrylamide, an efﬁcient neutral quencher probe [29] was
used. Stern–Volmer plots for the quenching of Trp by acrylamide,
recorded in the absence and presence of lipid vesicles, are shown in
Fig. 2B and the resultant Stern–Volmer constants are presented in
Table 2. Linear Stern–Volmer plots indicate that the Trp residue is
fairly accessible to acrylamide, and in all cases, the quenching of the
peptide Trp residue showed an acrylamide dependent concentration
Fig. 1. (A) Effect of the NS4BH1 (continuous line) and NS4BH1SC (dotted line) peptides on the release (membrane rupture) of CF for different lipid compositions. The lipid compositions
used were ER (◄), EPC (▼), BPS/CHOL at a molar ratio of 5:1 (■), EPA/CHOL at a molar ratio of 5:1 (○), EPC/CHOL at a molar ratio of 5:1 (∇), EPC/ESM/CHOL at a molar ratio of 5:1:1
(♦), EPC/EPA at amolar ratio of 5:2 (▲), EPC/BPS at amolar ratio of 5:2 (□), EPC/BPS/CHOL at amolar ratio of 5:3:1 (•) and EPC/TPE/CHOL at amolar ratio of 5:3:1 (◃). The ER complex
lipid mixture is composed of EPC/CL/BPI/TPE/BPS/EPA/ESM/CHOL at a molar ratio of 59:0.37:7.4:18:3.1:1.2:3.4:7.8 [22]. (B) Effect of the NS4BH1 peptide on the release (membrane
rupture) of CF for lipid compositions containing differentmolar ratios of EPC, ESM and CHOL. The lipid compositions usedwere EPC/ESM/CHOL at amolar ratio of 5:1:1 (♦), EPC/ESM/
CHOL at amolar ratio of 5:3:1 (•), EPC/ESM/CHOL at amolar ratio of 5:2:1 (◊), EPC/ESM/CHOL at amolar ratio of 5:4:1 (○), EPC/ESM/CHOL at amolar ratio of 5:5:1 (▲), EPC/ESM/CHOL
at amolar ratio of 5:2:0 (Δ), EPC/ESM/CHOL at amolar ratio of 5:2:2 (∇), EPC/ESM/CHOL at amolar ratio of 5:2:3 (◊), and EPC/ESM/CHOL at amolar ratio of 5:2:4 (▼). (C) Relationship
between the relative content of ESM and CHOL versus membrane rupture for lipid/peptide molar ratios of 30:1 (Δ), 25:1 (○) and 15:1 (□). The dotted line is the ﬁt to the ESM data
(R2=0.9278). (D) Effect of the NS4BH1 peptide on the release (membrane rupture) of CF for the ER58:6 complex lipid mixture (EPC/CL/BPI/TPE/BPS/EPA/ESM/CHOL at a molar ratio of
58:6:6:6.6:6:6:6) and its variations. The lipid compositions used were ER58:6 (◄), ER58:6 minus BPI (•), ER58:6 minus TPE (○), ER58:6 minus CHOL (■), ER58:6 minus ESM (□), ER58:6
minus BPS (▲), ER58:6 minus CL (Δ) and ER58:6 minus EPA (◃). Vertical bars indicate standard deviations of the mean of triplicate samples. See text for details.
Fig. 2. (A) Change on the ﬂuorescence intensity of the Trp residue of the NS4BH1 peptide in the presence of increasing lipid concentration, (B) Stern–Volmer plots for the quenching of
the ﬂuorescence of the Trp residue of the NS4BH1 peptide in the presence by acrylamide and (C) Stern–Volmer plots for the depth-dependent quenching of the ﬂuorescence of the
Trp residue of the NS4BH1 peptide in the presence of the 5-NS and 16-NS probes. The lipid compositions usedwere ER (◄), EPC (▼), BPS/CHOL at amolar ratio of 5:1 (■), EPA/CHOL at
a molar ratio of 5:1 (○), EPC/CHOL at a molar ratio of 5:1 (∇), EPC/ESM/CHOL at a molar ratio of 5:1:1 (♦), EPC/EPA at a molar ratio of 5:2 (▲), EPC/BPS at a molar ratio of 5:2 (□),
EPC/BPS/CHOL at a molar ratio of 5:3:1 (●), EPC/TPE/CHOL at a molar ratio of 5:3:1 (◃), EPC/EPA/CHOL at a molar ratio of 5:3:1 (Δ), and EPC/ESM/CHOL at a molar ratio of 5:3:1 (◊).
In (B), pure peptides are represented by (×). In (C) solid lines correspond to 5-NS and dotted lines to 16-NS. Vertical bars indicate standard deviations of the mean of triplicate
samples. The lipid to peptide ratio was 100:1 for experiments using acrylamide and NS probes.
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Table 2
Partition coefﬁcients (KP) and Stern–Volmer quenching constants (KSV) obtained from
the ﬂuorescence of the Trp residue of the NS4BH1 peptide in buffer and in the presence
of different model membranes.
LUV
COMPOSITION
KP (× 10-5 M­1)
Trp
Ksv (M­1)
Acrylamide
Ksv (M­1)
5-NS 16-NS
BPS/CHOL 5:1 3.30±0.6 3.50±0.2 9.70±0.9 9.3±1.6
EPA/CHOL 5:1 4.50±0.87 4.80±0.2 10.2±0.6 5.8±1.1
EPC/CHOL 5:1 0.88±0.5 10.2±0.2 7.30±0.2 2.8±0.7
EPC 1.10±0.9 11.6±0.2 – –
EPC/EPA 5:2 2.90±0.1 10.3±0.4 12.8±3.4 2.4±2.2
EPC/ESM/CHOL 5:3:1 1.14±0.4 15.4±0.7 1.93±0.3 1.5±0.5
EPC/BPS 5:2 1.09±0.7 16.2±0.8 7.40±1.7 6.8±1.9
EPC/ESM/CHOL 5:1:1 1.10±0.91 – – –
EPC/TPE/CHOL 5:3:1 0.78±0.51 – – –
EPC/EPA/CHOL 5:3:1 0.67±0.11 – – –
EPC/BPS/CHOL 5:3:1 0.90±0.26 – – –
ER complex mixture 0.47±0.2 – – –
Buffer – 21.4±1.2 – –
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the solvent that led to a more efﬁcient quenching. However, in the
presence of the phospholipid membranes, the extent of quenching
was signiﬁcantly reduced, indicating a poor accessibility of the Trp
residue to the aqueous phase, consistent with its incorporation into
the lipid bilayer. The NS4BH1SC peptide in solution gave a KSV of 11.3
M­1, suggesting a lesser accessibility of the peptide Trp to the solvent
than the NS4BH1 peptide (KSV of 21.4 M­1), assuming invariance of the
Trp lifetime. For the NS4BH1 peptide, the extent of quenching was
signiﬁcantly reduced in the presence of negatively charged phospho-
lipid membranes, in accordance with the results shown above. The
transverse location (penetration) of the NS4BH1 peptide in the lipid
bilayer was evaluated by monitoring the relative quenching of the
ﬂuorescence of the Trp residue by the lipophylic spin probes 5NS and
16NS when the peptide was incorporated in the ﬂuid phase of vesicles
having different phospholipid compositions (Fig. 2C), whereas the KSV
values for both probes are presented in Table 2. In general, 16-NS
quenches the peptides ﬂuorescence less efﬁciently than 5-NS, but the
difference between the two probes is not very high. These data allow
us to conclude that the Trp residue resides in between these probes,
but nearer to the 5-NS probe than to the 16-NS one.3.4. Perturbation induced by the peptide in the lipid palisade
Membrane lipids undergo a cooperative melting reaction, which is
linked to the loss of conformational order of the lipid chains and it has
been known for a long time that the melting process of membrane
lipids is inﬂuenced bymany types of molecules including proteins and
peptides. The effect of the NS4BH1 peptide on the structural and
thermotropic properties of phospholipidmembraneswas investigated
by measuring the steady-state ﬂuorescence anisotropy of the
ﬂuorescent probes DPH and TMA-DPH incorporated into model
membranes composed of saturated synthetic phospholipids as a
function of temperature (Fig. 3). DPH is known to partitionmainly into
the hydrophobic core of themembrane,whereas TMA-DPH is oriented
at the membrane bilayer with its charge localized at the lipid-water
interface [39]. Their different location and orientation in the
membrane allows to analyze the effect of the NS4BH1 peptide on the
structural and thermotropic properties along the full length of the
membrane. In the case of DMPC, the NS4BH1 peptide decreased the
cooperativity of the thermal transition and in addition elicited a shift of
about 2–4 °C to lower temperatures of the Tm (Fig. 3A and B). However,
the anisotropy of both DPH and TMA-DPH above and below the Tm of
DMPC was not signiﬁcantly changed. NS4BH1 decreased the coopera-
tivity of the phospholipid transition of DMPG, decreased and increasedthe anisotropy of bothDPH and TMA-DPHbelow and above the Tm, but
did not decrease signiﬁcantly the temperature of the thermal
transition of DMPG (Fig. 3C and D). The decrease in cooperativity of
DMPGelicited by the peptide is perfectly visible in the derivative of the
curves (inserts, Fig. 3C and D). For DMPS and DMPA bilayers, NS4BH1
did not changed signiﬁcantly the cooperativity of their respective
transitions as well as the anisotropy below and above the Tm , but
induced a shift of about 2–4 °C to lower temperatures of the Tm (Fig. 3E
and F and Fig. 3G andH forDMPSandDMPA, respectively). NS4BH1was
able of affecting the thermal transition Tm for all phospholipids as
observedby both types of probes,was able to perturb the phospholipid
acyl chains and therefore should be located at the lipid-water interface
inﬂuencing the ﬂuidity of the phospholipids [28]. The difference in
charge between the phospholipid head-groups affects but slightly the
peptide incorporation into the lipid bilayer.
As noted above, it seems that there is a speciﬁc interaction between
the NS4BH1 peptide and sphingomyelin. Because of that we have also
studied the effect of the NS4BH1 peptide on the thermotropic phase
behavior of phospholipidmultilamellar vesicles containing either ESMor
PSM using differential scanning calorimetry (DSC). The corresponding
proﬁles are shown in Fig. 4. DMPC, which have not been extensively
annealed at low temperatures, displays two endothermic peaks on
heating, the pre-transition (12–14 °C, Lβ’-Pβ’) and the main transition
(24 °C, Pβ’-Lα). As illustrated in Fig. 4A, incorporation of NS4BH1 at a lipid/
peptide ratio of 15:1 signiﬁcantly altered the thermotropic behavior of
DMPC, since the peptide abolished completely the pre-transition of the
phospholipid, as well as signiﬁcantly broadened the transition of DMPC
in accordance with the anisotropy results commented above. The main
transition is apparently composed of at least two different peaks, which
should be due tomixed phases. In a similarway, incorporation of NS4BH1
into PSMmembranes at a lipid/peptide ratio of 15:1 signiﬁcantly altered
the thermotropic behavior of the phospholipid (Fig. 4B). The peptide
broadened the main transition of PSM and apparently gave place to at
least two different peaks, which should be also due to mixed phases.
Incorporation of NS4BH1 into binary membranes composed of DMPC/
ESM and DMPC/PSM at molar ratios of 5:3 changed considerably the
thermotropic behavior of themixtures (Fig 4C and D). The slightly broad
transition of the binary mixture was broadened by the presence of the
peptide and, at lipid/peptide molar ratios of 5:1, three thermotropic
transitionswere noticeable: at about 28, 35 and 46 °C. Theﬁrst transition
should correspond to a phase enriched in DMPC, the second one to a
phase consisting of a mixture of both DMPC and either ESM or PSM and
the thirdone to aphaseenriched in either ESMorPSM. The coexistenceof
different phases induced by the presence of NS4BH1 would indicate that
one of them would be enriched in peptide (phospholipids highly
disturbed) whereas the other ones would be impoverished in them
(phospholipids slightly disturbed).
3.5. Secondary structure of the NS4BH1 peptide
The existence of structural changes on the NS4BH1 peptide induced
by membrane binding was studied by analyzing the infrared Amide I′
band located between 1700 and 1600 cm­1. The Amide I′ region of the
fully hydrated peptide in buffer is shown in Fig. 5A. For the peptide in
solution and at low temperatures, the Amide I′ band was asymmetric
with a maximum at about 1647 cm­1 and one shoulder at about 1672
cm­1. The broad band with the intensity maxima at about 1647 cm­1
would mainly correspond to a mixture of unordered and helical
structures, whereas the bandwith the intensitymaxima at about 1672
cm­1would correspond toβ-sheet [40,41]. Increasing the temperature,
the band with the maximum at 1647 cm­1 slightly broadened and
increased in frequency to about 1649 cm­1 (Fig. 5E) and at the same
time a shoulder appeared at about 1615 cm­1,whichwould correspond
to aggregated structures (Fig. 5A). These data would imply that the
NS4BH1 peptide changed from a mixture of helical, unordered and β-
sheet structures at low temperatures to a mixture of helical,
Fig. 3. Steady-state anisotropy, brN, of TMA-DPH (A, C, E and G) and DPH (B, D, F and H) incorporated into (A and B) DMPC, (C and D) DMPG , (E and F) DMPS and (G and H) DMPA
model membranes as a function of temperature. Data correspond to vesicles containing pure phospholipid (●) and phospholipid plus NS4BH1 peptide at a 15:1 molar ratio (○). The
inserts show the normalized 13-point smoothed ﬁrst derivative of the curves.
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Furthermore, this transitional change in overall structure occurs at
about 42–48 °C (Fig. 5E).
In the presence of DMPC and at low temperatures, the Amide I′
envelope of NS4BH1 was similar to that observed for the peptide in
solution (Fig. 5B). However, at approximately 42 °C a band at
approximately 1615 cm­1 was apparent; this band increased in
intensity as the temperature increased and at the same time the broad
band at 1646 cm­1 decreased in intensity with no change above 60 °C
(Fig. 5B and F). These changes in band intensity show that NS4BH1, in
the presence of DMPC, presents a high percentage of unordered and
helical structures at low temperatures but a high percentage of
aggregated structures at higher ones. Themaximum of the ester C=O
band of DMPC in the presence of NS4BH1, displayed two broad
transitions, one between 20 and 28 °C (from 1738 cm­1 to 1734 cm­1)
and another one at about 42–60 °C (from 1734 cm­1 to 1732 cm­1).
The ﬁrst broad transition which appears at about 20–28 °C coincides
with the gel-to-liquid crystalline phase transition of DMPC (see Fig. 3Cand D), whereas the second broad 42–60 °C transition coincides with
the structural change of NS4BH1 commented above. These results
imply that NS4BH1 affects the molecule of DMPG and at the same
DMPG affects the NS4BH1 peptide.
In the presence of DMPG and at low temperatures, the Amide I´
envelope of NS4BH1 was similar to that observed for the peptide in
solution at relatively high temperatures, with a broad band at about
1646 cm­1 and a shoulder at about 1615 cm­1 (Fig. 5C). The relative
intensity of the two bands changed as the temperature increased
giving place to three broad transitions, i.e., about 22 °C, 44 °C and
60 °C (Fig. 5C and G). These changes in band intensity show that
NS4BH1, in the presence of DMPG, oscillates between a mixture of
unordered and helical structures and a mixture of unordered, helical
and aggregated structures. The ester C=O band of DMPG in the
presence of NS4BH1 presented two maxima at about 1738 cm­1 and
1723 cm­1 at low temperatures (Fig. 5C). These two relatively sharp
bands coalesced into a broad band which changed in frequency as the
temperature increased; this broad C=O band of DMPG showed two
Fig. 4.Differential scanning calorimetry heating-scan thermograms for (A) DMPC and DMPC/NS4BH1 15:1, (B) PSM and PSM/NS4BH1 at a molar ratio of 15:1, (C) ESM, ESM/NS4BH1 at
a molar ratio of 15:1, and ESM/NS4BH1 at a molar ratio of 5:1, and (D) PSM, PSM/NS4BH1 at a molar ratio of 15:1, and PSM/NS4BH1 at a molar ratio of 5:1. All thermograms were
normalized to the same amount of lipid.
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(Fig. 5G). DMPG, as a phosphatidylglycerol phospholipid, can exhibit
under physiologically relevant conditions a more complex pattern of
thermotropic phase behavior than the corresponding zwitterionic
phosphatidylcholine DMPC, which could include the formation of one
or more high melting crystalline or quasi-crystalline lamellar phases
and the formation of extended three-dimensional bilayer networks
where curvature elasticity is of primary relevance [42,43].The pattern
of thermotropic phase behavior exhibited by freshly dispersed
samples of DMPG is remarkably similar to that of DMPC. However,
incubation of phosphatidylglycerols at low temperatures results in the
formation of one or more quasi-crystalline structures at rates
dependent on the hydrocarbon chain length, i.e., Lc1b and Lc2 phases
[42,43]. The appearance of two sharps C=O bands in DMPG at
relatively low temperatures, as shown in Fig. 5C, suggest that a new
phase, likely the Lc1b phase, is induced at low temperatures by the
presence of the NS4BH1 peptide. These results show that both types of
molecules, NS4BH1 and DMPG, sense at the same time all these
transitions, i.e., both types of molecules affect each other, a new phase
is induced at low temperatures, and furthermore, these interactions
might have large implications for different biological processes and
particularly to membrane perturbation.
The Amide I′ envelope of NS4BH1 in the presence of DMPA displayed
a intense narrow band at about 1616 cm­1, a broad band with a
maximum at about 1645 cm­1, and two small bands at about 1684 and
1670 cm­1 (Fig. 5D). The bands at about 1685 and 1616 cm­1 should
correspond to aggregated structures, the broad band at about 1645 cm­1
would mainly correspond to a mixture of unordered and helicalstructures, whereas the band at about 1670 cm­1 would correspond to
β-sheet structures [40,41]. Increasing the temperature, a change in
frequency is apparent in the narrow band, since it moves from about
1615 to 1623 cm­1 with a transition between 70 and 74 °C, at the same
time that the small band at 1685 cm­1 disappears and the other small
band at 1670 cm­1 moves to about 1674 cm­1 (Fig. 5D and H). The
disappearanceof the bandat1685cm­1witha concomitant change from
the band at 1615 to 1623 cm­1 indicates that the aggregated structures
transformmost probably toβ-sheet structures [40,41]. Themaximumof
the ester C=O band of DMPA in the presence of NS4BH1 displayed two
transitions, one beginning at about 51 °C (from 1738 to 1735 cm­1) and
the other one beginning at about 68 °C (from 1735 to 1732 cm­1)
(Fig. 5H). The ﬁrst transition is related to the gel-to-liquid crystalline
phase transition of DMPA (see Fig. 3), whereas the second broad one
coincides with the structural change of NS4BH1 commented above.
These results imply that NS4BH1 affects the DMPA molecule and at the
same DMPA affects the secondary structure of the NS4BH1 peptide.
4. Discussion
The replication and assembly of HCV, which remains essentially
unclear, has beensuggested tooccur in theERor ER-derivedmembranes
[8–10,44]. Most, if not all, of the HCV NS proteins including NS4B, play a
central role in viral particle formation and budding, but their speciﬁc
function in replication and/or assembly remains poorly understood
[6,7]. NS4B, a highly hydrophobic protein, has been suggested to alter ER
membranes so that the HCV replication complex can be formed and
therefore has a critical role in HCV formation. Since the biological role/
Fig. 5. Stacked infrared spectra in the C=O and Amide I′ region for the NS4BH1 peptide in solution (A) and in the presence of DMPC (B), DMPG (C) and DMPA (D) at different
temperatures as indicated. The phospholipid-to-peptide molar ratio was 15:1. The temperature dependence of the 1646 cm­1/1616 cm­1 intensity relationship (■), Amide I′
maximum (▲) and C=Omaximum (♦) for the NS4BH1 peptide in solution and in the presence of DMPC, DMPG and DMPA are shown in E, F, G and H, respectively. See text for details.
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extended our previous work [19] to investigate the binding and
interaction of the membranotropic highly conserved H1 region of
NS4B, i.e., peptide NS4BH1, with membrane model systems. We have
carried out an in-depth biophysical study aimed to elucidate the
capacity of this region to interact and disrupt membranes, as well as to
study the structural and dynamic features which might be relevant forthat disruption. Our ﬁndings give some clues to a key region in the viral
protein that might be implicated in the HCV life cycle, and therefore
could be used as a new target for searching inhibitors of viral replication
and assembly.
The NS4BH1 peptide was capable of altering membrane stability
causing the release of ﬂuorescent probes, this effect being dependent
on lipid composition and on the lipid/peptide molar ratio. The highest
1228 M.F. Palomares-Jerez, J. Villalaín / Biochimica et Biophysica Acta 1808 (2011) 1219–1229release was observed for liposomes containing negatively charged
phospholipids, although signiﬁcant leakage values were also observed
for liposomes composed of zwitterionic phospholipids. A scrambled
peptide did not induce membrane leakage at all, indicating that the
speciﬁc sequence of NS4BH1 is fundamental to observe any effect.
Interestingly, the ESM and CHOL content also modulated membrane
rupture, since ESM increased but CHOL decreased the leakage extent.
This differences could be a consequence of inﬂuence of cholesterol in
the membrane penetration of peptides attenuating its insertion as it
has been observed for other peptides [45]. These results were
corroborated by using a speciﬁc ER complex membrane, indicating
that the speciﬁc disrupting effect elicited by the NS4BH1 peptide
should depend on the phospholipid head-group characteristics, i.e.,
charge and possibly hydrogen bonding, although hydrophobic
interactions within the bilayer should not be ruled out. The fact that
the scrambled peptide did not interact in the same way with the
membrane supports the importance of the speciﬁcity on the primary
amino acid sequence of this peptide.
We have also shown that the NS4BH1 peptide binds with high
afﬁnity to phospholipid model membranes, as it has been similarly
found for other peptides [36,38]. Binding was further demonstrated
by hydrophilic quenching probes, since the NS4BH1 peptide was less
accessible for quenching by acrylamide implying a buried location.
The lipophylic probe quenching results suggest a shallow-to-inter-
mediate location of the peptide in the membrane, but the extent of
quenching is relatively low compared to other peptides [30,46,47].
Interestingly, these data suggest that the insertion of the peptide into
the bilayer palisade depends on phospholipid composition. We have
also shown that the NS4BH1 peptide is capable of affecting the steady-
state ﬂuorescence anisotropy of ﬂuorescent probes located into the
palisade structure of the membrane, since the peptide was able of
decreasing the mobility and cooperativity of the phospholipid acyl
chains when compared to the pure phospholipids. Calorimetry
experiments further corroborated these results, and additionally
indicated that the NS4BH1 peptide induced the presence of mixed
lipid phases, enriched and impoverished in peptide. This result
strengthens that the location of the peptide is at or near the
membrane interface, inﬂuencing the ﬂuidity of the phospholipids,
most probably with an in-plane orientation rather than in a
transmembrane position [48].
The infrared spectra of the Amide I′ region of the fully hydrated
peptide in solution at low temperatures displayed a coexistence of
α-helix, β-sheet and random structures; at about 42–48 °C a broad
transition with a concomitant increase in aggregated structures
occurred. In the presence of different types of phospholipids as well
as at different temperatures, different amounts of secondary structures
were found. At the same time, differences in the frequency andnumber
of bands corresponding to the carbonyl band of the phospholipids
were observed. However, and most important, the changes which
were observed were coincidental with each other, implying that both
types of molecules affected one to the other and vice versa. These
results imply that the secondary structure of the NS4BH1 peptide was
affected by its binding to the membrane, so that membrane binding
modulates the secondary structure of the peptide as it has been
suggested for other peptides [19,49].
The binding of peptide NS4BH1 to the surface of the membrane and
the modulation of the phospholipid biophysical properties which takes
place as a consequence of binding could be related to the conformational
changes which might occur during the biological activity of the NS4B
protein. Consequently the NS4B region where peptide NS4BH1 resides
might have an essential role in the membrane replication and/or
assembly of the viral particle through the modulation of themembrane
structure and hence the replication complex. The conservation of its
structure as well as its physical and chemical properties should be
essential in its function, since changes in the primary sequence prevent
the resulting peptide from interacting with the membrane. Our resultsadd new information about how this region can contribute to the
interaction with the membrane. Although the peptide is not deeply
buried in themembrane, its interactionwith themembrane depends on
its composition and it is able to affect the lipid milieu from the
membrane surface down to the hydrophobic core. Consequently, our
results identify an important region in the HCV NS4B protein which
might be directly implicated in the HCV life cycle. Additionally,
pharmacological disruption of NS4B interaction with membranes
could represent the basis for a novel approach to anti-HCV therapy.Acknowledgements
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